TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Envor Biotech Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
40,543
|
51,686
|
54,037 |
| Financial expenses |
1,445
|
1,348
|
1,457 |
| Earnings before taxes |
-4,034
|
-4,952
|
-18 |
| Total assets |
63,322
|
70,765
|
71,672 |
| Current assets |
145
|
220
|
326 |
| Current liabilities |
47,249
|
45,013
|
36,212 |
| Equity capital |
13,239
|
15,629
|
14,876 |
| - share capital |
791
|
832
|
787 |
| Employees (average) |
6
|
5 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
20.9%
|
22.1%
|
20.8% |
| Turnover per employee |
8,614
|
10,807 | |
| Profit as a percentage of turnover |
-9.9%
|
-9.6%
|
0.0% |
| Return on assets (ROA) |
-4.1%
|
-5.1%
|
2.0% |
| Current ratio |
0.3%
|
0.5%
|
0.9% |
| Return on equity (ROE) |
-30.5%
|
-31.7%
|
-0.1% |
| Change turnover |
-8,587
|
-5,401
|
14,496 |
| Change turnover % |
-17%
|
-9%
|
37% |
| Chg. No. of employees |
1
|
-1 | |
| Chg. No. of employees % |
20%
|
-17% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.